User test in Sweden, Germany and Denmark
Huge user tests have been performed in both Sweden and Germany, with the aim to test if the positive results from the clinical studies could be verified by users in general. Therefore 1000 patients in each country were asked to test the Asonor solution for 1 month. The results lived completely up to the results from the Clinical Studies, that approximately 3 out of 4 had benefits from using Asonor solution against snoring.
Asonor® in Denmark
Asonor® is a recognized consumer brand and is sold in major part of pharmacies in Denmark.
Asonor® nose spray is an effective treatment of heavy snoring and is an award-winning formula.
Asonor® is the market leader in Denmark within its category.
Asonor® effect on snoring is clinically proven and was in 2005 registered by the health authorities in EU, in accordance with the requirements of the Directive 93/42/EEC. The classification and the documentation of the safety and effect against snoring fully comply with Directive 93/42/EEC.
Asonor® is produced in accordance with the guidelines for production of medicine at GMP facilities in EU.
There are no known or registered side effects from using Asonor®
